Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.4K Buy
219
+66
+43% +$7.26K ﹤0.01% 369
2026
Q1
$16.1K Buy
153
+5
+3% +$587 ﹤0.01% 368
2025
Q4
$18.5K Buy
148
+98
+196% +$11.7K ﹤0.01% 258
2025
Q3
$6K Hold
50
﹤0.01% 518
2025
Q2
$4.59K Hold
50
﹤0.01% 533
2025
Q1
$4.4K Hold
50
﹤0.01% 565
2024
Q4
$4.63K Hold
50
﹤0.01% 517
2024
Q3
$4.64K Buy
+50
New +$4.2K ﹤0.01% 500
2024
Q1
Sell
-24
Closed -$1.66K 574
2023
Q4
$1.66K Buy
+24
New +$1.45K ﹤0.01% 675

Other funds holding CRH

Arlington Trust's CRH Position: Q2 2026 in Review

Arlington Trust increased its CRH (CRH) stake by 43% in Q2 2026, buying an estimated $7.26K and bringing the position to 219 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Arlington Trust first reported a position in CRH in Q4 2023 and has held it in 9 quarters since. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Arlington Trust held 219 shares of CRH worth $23.4K as of Q2 2026.
  • Arlington Trust bought 66 CRH shares in Q2 2026, an estimated $7.26K.
  • CRH made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #369 holding.
  • Arlington Trust first reported a position in CRH in Q4 2023 and has held it in 9 quarters since.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.